Literature DB >> 11519480

Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

P Ferrante1, M Mediati, R Caldarelli-Stefano, L Losciale, R Mancuso, A E Cagni, R Maserati.   

Abstract

To verify the possibility of different role of JC virus genotypes in the etiology of progressive multifocal leukoencephalopathy, we analysed several JC virus isolates amplified from AIDS patients with and without progressive multifocal leukoencephalopathy and healthy controls by nucleotide sequencing. Cerebrospinal fluid (CSF), peripheral blood mononuclear cells (PBMCs) and urine from 52 AIDS patients suffering from various neurological diseases including 21 cases of progressive multifocal leukoencephalopathy, and PBMCs and urine from healthy subjects were evaluated by nested polymerase chain reaction (PCR) for the presence of DNA belonging to the highly conserved large T antigen (LT) of JC virus. The different JC virus subtypes were identified by nucleotide sequence analysis of the virion protein (VP1) genomic region. JC virus DNA was detected in all the CSF samples from the progressive multifocal leukoencephalopathy patients, but not in the CSF from non-progressive multifocal leukoencephalopathy cases, while the frequency of JC virus DNA detection in the PBMCs and urine did not differ among the three groups studied. JC virus type 2 was detected only in progressive multifocal leukoencephalopathy patients, and in particular in 52.4% of their CSF samples. Moreover, in the CSF of 19.0% of the progressive multifocal leukoencephalopathy cases, dual infection with both JC virus types 1 and 2 was found. The data obtained in this study indicate that the unexpected involvement of JC virus type 2, a strain not common in Italy, and the high frequency of dual infection with both JC virus types 1 and 2 in progressive multifocal leukoencephalopathy CSF, can be indications of risk factors for progressive multifocal leukoencephalopathy development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519480     DOI: 10.1080/135502801300069638

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  32 in total

Review 1.  Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare.

Authors:  J R Berger; M Concha
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

2.  Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypes.

Authors:  A Vallejo; P Ferrante; V Soriano; M L Calabrò; R Mancuso; A Heredia; E Mannella; A Favero; A Garcia-Sáiz; L Chieco-Bianchi; J González-Lahoz; I K Hewlett
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-12-01

3.  Multiple JC virus genomes from one patient.

Authors:  J D Martin; G C Foster
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

4.  Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy.

Authors:  P Ferrante; R Caldarelli-Stefano; E Omodeo-Zorini; A E Cagni; L Cocchi; F Suter; R Maserati
Journal:  J Med Virol       Date:  1997-07       Impact factor: 2.327

5.  Manifold sequencing: efficient processing of large sets of sequencing reactions.

Authors:  A Lagerkvist; J Stewart; M Lagerström-Fermér; U Landegren
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  Evidence for a shift in 5'-termini of early viral RNA during the lytic cycle of JC virus.

Authors:  K Khalili; L Feigenbaum; G Khoury
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

7.  Regulation of the host range of human papovavirus JCV.

Authors:  L Feigenbaum; K Khalili; E Major; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  JC virus type 2B is found more frequently in brain tissue of progressive multifocal leukoencephalopathy patients than in urine from controls.

Authors:  H T Agostini; C F Ryschkewitsch; E J Singer; R W Baumhefner; G L Stoner
Journal:  J Hum Virol       Date:  1998 Mar-Apr

9.  Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration.

Authors:  H T Agostini; R Yanagihara; V Davis; C F Ryschkewitsch; G L Stoner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

10.  BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania.

Authors:  H T Agostini; G R Brubaker; J Shao; A Levin; C F Ryschkewitsch; W A Blattner; G L Stoner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more
  14 in total

1.  JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy.

Authors:  L A Pfister; N L Letvin; I J Koralnik
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Authors:  Serena Delbue; Emanuela Branchetti; Renzo Boldorini; Luca Vago; Pietro Zerbi; Claudia Veggiani; Sara Tremolada; Pasquale Ferrante
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

3.  Reply to letter to the editor: "JC viremia and multiple sclerosis" by Focosi et al.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

4.  A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine.

Authors:  Serena Delbue; Giovanni Sotgiu; Daniela Fumagalli; Marilena Valli; Elisa Borghi; Roberta Mancuso; Enrico Marchioni; Renato Maserati; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

5.  Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.

Authors:  Pasquale Ferrante; Serena Delbue; Elisabetta Pagani; Roberta Mancuso; Angela Marzocchetti; Elisa Borghi; Renato Maserati; Arabella Bestetti; Paola Cinque
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

6.  JC virus in the Irish population: significant increase of genotype 2 in immunocompromised individuals.

Authors:  Kirsten Schaffer; Noreen Sheehy; Suzie Coughlan; Colm Bergin; William W Hall
Journal:  J Neurovirol       Date:  2006-02       Impact factor: 2.643

7.  JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Eleonora Tavazzi; Enrico Marchioni; Silvia Carluccio; Lucia Signorini; Stefano Novati; Renato Maserati; Pasquale Ferrante
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

8.  Molecular analysis of JC virus genotypes circulating among the Italian healthy population.

Authors:  Elisabetta Pagani; Serena Delbue; Roberta Mancuso; Elisa Borghi; Letizia Tarantini; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

9.  Analysis of variability of urinary excreted JC virus strains in patients infected with HIV and healthy donors.

Authors:  Danijela Karalic; Ivana Lazarevic; Ana Banko; Maja Cupic; Djordje Jevtovic; Tanja Jovanovic
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

10.  Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.

Authors:  Angela Marzocchetti; Maurizio Sanguinetti; Simona Di Giambenedetto; Antonella Cingolani; Giovanni Fadda; Roberto Cauda; Andrea De Luca
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.